New type of cardiomyopathy associated with diabetic glomerulosclerosis.

PubWeight™: 4.86‹?› | Rank: Top 1%

🔗 View Article (PMID 4263660)

Published in Am J Cardiol on November 08, 1972

Authors

S Rubler, J Dlugash, Y Z Yuceoglu, T Kumral, A W Branwood, A Grishman

Associated clinical trials:

Pilot Study to Assess the Proteome in Human Atrial Tissue | NCT00591903

Articles citing this

(truncated to the top 100)

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest (2002) 4.22

A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci U S A (2003) 2.68

Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest (1977) 2.53

Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord (2010) 2.47

The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol (2010) 2.37

Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study. Circ Heart Fail (2015) 2.02

Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation (2007) 1.86

Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J Clin Invest (2012) 1.63

Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Circ Res (2013) 1.61

Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev (2012) 1.61

Cardiac dysfunction during exercise in uncomplicated type 2 diabetes. Med Sci Sports Exerc (2009) 1.54

Molecular mechanisms of diabetic cardiomyopathy. Diabetologia (2014) 1.53

Mitochondria in the diabetic heart. Cardiovasc Res (2010) 1.50

Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev (2013) 1.44

Left ventricular function in diabetes mellitus. I: Methodology, and prevalence and spectrum of abnormalities. Br Heart J (1981) 1.33

O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function. Circ Res (2008) 1.32

Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling. Circ Heart Fail (2011) 1.32

Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb Perspect Biol (2011) 1.31

A Drosophila model of high sugar diet-induced cardiomyopathy. PLoS Genet (2013) 1.28

Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets. Drug Discov Today Dis Mech (2010) 1.28

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag (2010) 1.24

Diabetic cardiomyopathy? An echocardiographic study of young diabetics. Br Med J (1978) 1.23

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol (2012) 1.22

Diabetic cardiomyopathy: bench to bedside. Heart Fail Clin (2012) 1.19

Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol (1993) 1.19

Diabetic cardiomyopathy. Clin Sci (Lond) (2009) 1.18

Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia (2010) 1.18

Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens (2010) 1.16

Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Cardiovasc Diabetol (2010) 1.16

Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance. Diabetes (2013) 1.14

Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta (2014) 1.12

Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol (2003) 1.12

Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response. J Biol Chem (2011) 1.11

Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management. World J Diabetes (2013) 1.10

Aldose reductase, oxidative stress, and diabetic mellitus. Front Pharmacol (2012) 1.10

Diabetic cardiomyopathy: the preclinical phase. Br Med J (1977) 1.07

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol (2015) 1.07

Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI). Cardiovasc Diabetol (2007) 1.06

Diabetic heart disease. Heart (2005) 1.06

Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes (2013) 1.05

Left ventricular function in diabetes mellitus. II: Relation between clinical features and left ventricular function. Br Heart J (1981) 1.05

Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta (2014) 1.04

Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy. Curr Cardiol Rev (2010) 1.03

Type 2 diabetes, mitochondrial biology and the heart. J Mol Cell Cardiol (2009) 1.03

Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. PLoS One (2013) 1.01

Diabetic cardiomyopathy and metabolic remodeling of the heart. Life Sci (2012) 1.00

Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes (2010) 1.00

Insulin resistance and risk of incident heart failure: Cardiovascular Health Study. Circ Heart Fail (2013) 0.99

Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies. Curr Pharm Des (2013) 0.99

Altered calcium homeostasis does not explain the contractile deficit of diabetic cardiomyopathy. Diabetes (2008) 0.99

Causes and characteristics of diabetic cardiomyopathy. Rev Diabet Stud (2006) 0.99

Hyperglycemia and nocturnal systolic blood pressure are associated with left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients. Cardiovasc Diabetol (2006) 0.98

Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease. Am J Pathol (1981) 0.98

Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart Vessels (1985) 0.97

MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy. Am J Pathol (2011) 0.97

Diabetic cardiomyopathy: signaling defects and therapeutic approaches. Expert Rev Cardiovasc Ther (2010) 0.97

Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis. J Mol Cell Cardiol (2009) 0.96

A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels (1997) 0.96

Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy. Am J Physiol Regul Integr Comp Physiol (2008) 0.95

Prospective study of heart disease in untreated maturity onset diabetics. Br Heart J (1980) 0.95

Cardiomyopathic syndrome due to coronary arter disease. II: Increased prevalence in patients with diabetes mellitus: a matched pair analysis. Br Heart J (1977) 0.95

Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage. J Diabetes Investig (2014) 0.94

Diabetic Cardiomyopathy in OVE26 Mice Shows Mitochondrial ROS Production and Divergence Between In Vivo and In Vitro Contractility. Rev Diabet Stud (2007) 0.94

Over-nutrition and metabolic cardiomyopathy. Metabolism (2012) 0.94

Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol (2008) 0.94

A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications. Vasc Health Risk Manag (2007) 0.93

The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota. J Card Fail (2014) 0.93

Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease. Cardiovasc Diabetol (2011) 0.93

Abnormal left ventricular torsion and cardiac autonomic dysfunction in subjects with type 1 diabetes mellitus. Metabolism (2011) 0.93

Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction. Regul Pept (2012) 0.93

Role of microangiopathy in diabetic cardiomyopathy. Heart Fail Rev (2014) 0.92

Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul study. Diabetes Care (2010) 0.91

Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress. Cardiovasc Diabetol (2012) 0.91

Cardiac H2S Generation Is Reduced in Ageing Diabetic Mice. Oxid Med Cell Longev (2015) 0.90

Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis. Cardiovasc Diabetol (2011) 0.90

Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice. Circ Heart Fail (2015) 0.90

[Heart failure in diabetes]. Wien Med Wochenschr (2009) 0.90

Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. J Mol Cell Cardiol (2012) 0.89

Investigation of the Protective Effects of Phlorizin on Diabetic Cardiomyopathy in db/db Mice by Quantitative Proteomics. J Diabetes Res (2013) 0.89

Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione. J Card Fail (2007) 0.89

Low Intensity Physical Exercise Attenuates Cardiac Remodeling and Myocardial Oxidative Stress and Dysfunction in Diabetic Rats. J Diabetes Res (2015) 0.89

Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes. Diabetes (2015) 0.88

Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation. Cardiovasc Diabetol (2014) 0.88

Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition. J Physiol (2002) 0.88

Garlic attenuates cardiac oxidative stress via activation of PI3K/AKT/Nrf2-Keap1 pathway in fructose-fed diabetic rat. PLoS One (2014) 0.88

Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress. Am J Physiol Cell Physiol (2010) 0.88

Peroxisome proliferator activated receptor-alpha (PPARα) and PPAR gamma coactivator-1alpha (PGC-1α) regulation of cardiac metabolism in diabetes. Pediatr Cardiol (2011) 0.88

FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation. J Cell Mol Med (2015) 0.88

Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a. PLoS One (2009) 0.88

Hydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress. Nitric Oxide (2015) 0.88

Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function. Microsc Microanal (2012) 0.88

The critical role of Astragalus polysaccharides for the improvement of PPARα [ correction of PPRAα]-mediated lipotoxicity in diabetic cardiomyopathy. PLoS One (2012) 0.87

Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes. PLoS One (2013) 0.87

Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats. Croat Med J (2013) 0.87

Cardiovascular impairment in children, adolescents, and young adults with type 1 diabetes mellitus (T1DM). Eur J Pediatr (2007) 0.86

Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol Cell Biochem (1997) 0.86

Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc Diabetol (2015) 0.86

The PPARalpha-PGC-1alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium. PPAR Res (2008) 0.86

Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects. Cardiovasc Diabetol (2015) 0.85

Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats. J Zhejiang Univ Sci B (2015) 0.85

Articles by these authors

Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. Am Heart J (1974) 1.22

Sickle cell states and cardiomyopathy. Sudden death due to pulmonary thrombosis and infarction. Am J Cardiol (1967) 1.01

Exercise testing with myocardial scintigraphy in asymptomatic diabetic males. Circulation (1981) 0.95

Transvenous electrical pacing of the heart. Results of 96 insertions in 78 patients. Am Heart J (1966) 0.91

Haemodynamic effects of isoprenaline in acute myocardial infarction. Br Heart J (1972) 0.90

Noninvasive estimation of myocardial performance in patients with diabetes. Effect of alcohol administration. Diabetes (1978) 0.90

Hemodynamic effects of isoproterenol in cardiac surgery. J Thorac Cardiovasc Surg (1971) 0.87

Bifascicular block: a clinical and electrophysiologic study. Am Heart J (1973) 0.86

Cardiac hypertrophy in response to dynamic conditioning in female athletes. J Appl Physiol Respir Environ Exerc Physiol (1978) 0.84

Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure. Br Heart J (1975) 0.84

Comparison of left atrial size and pulmonary capillary pressure with P wave of electrocardiogram. Am Heart J (1976) 0.83

Mitral valve obstruction in a case of bacterial endocarditis due to Corynebacterium hofmanii: echocardiographic diagnosis. N Y State J Med (1982) 0.83

Pulmonary edema associated with pulmonary embolism: a clinicopathological study. Angiology (1971) 0.82

Cardiac size and performance during pregnancy estimated with echocardiography. Am J Cardiol (1977) 0.81

The role of aortic valve calcium in the detection of aortic stenosis: an echocardiographic study. Am Heart J (1985) 0.81

Predictive value of clinical and exercise variables for detection of coronary artery disease in men with diabetes mellitus. Am J Cardiol (1987) 0.80

Collagen-derived membrane: corneal implantation. Science (1967) 0.79

The development of coronary thrombosis following myocardial infarction. Lipids (1978) 0.79

Left ventricular ejection times during exercise testing with scintigraphy. Their use in the detection of ischemic heart disease. Arch Intern Med (1984) 0.78

Mitral and tricuspid valve regurgitation in dilated cardiomyopathy. Am J Cardiol (1989) 0.78

Effect of cilazapril on exercise tolerance in congestive heart failure. Pharmacology (1993) 0.77

Exercise testing in young asymptomatic diabetic patients. Angiology (1976) 0.77

Diastolic time intervals in ischemic and hypertensive heart disease: A comparison of isovolumic relaxation time and rapid filling time with systolic time intervals. Chest (1975) 0.77

Systolic time intervals in pregnancy and the postpartum period. Am Heart J (1973) 0.76

Arm exercise testing with myocardial scintigraphy in asymptomatic patients with peripheral vascular disease. Chest (1989) 0.76

Blood pressure and heart rate responses during 24-hour ambulatory monitoring and exercise in men with diabetes mellitus. Am J Cardiol (1985) 0.76

Exercise testing for right ventricular ischemia. Am J Cardiol (1990) 0.75

The T loop in right bundle branch block. A vectorcardiographic study of 82 cases. Am Heart J (1968) 0.75

Letters to the editor: Left ventricular function in diabetes mellitus. Am Heart J (1975) 0.75

Beta-glucuronidase activity and its variation with pH in human atherosclerotic arteries. J Atheroscler Res (1967) 0.75

Isovolumic relaxation time in normal subjects and patients with cardiac disease: comparison of determinations made with echocardiographic techniques and apex cardiography. Angiology (1978) 0.75

Ambulatory blood pressure monitoring in diabetic males: a method for detecting blood pressure elevations undisclosed by conventional methods. Clin Cardiol (1982) 0.75

Recurrent ventricular fibrillation treated with countershocks, bretylium tosylate, and rapid cardiac pacing. N Y State J Med (1972) 0.75

Auscultation and phonocardiography. Adv Cardiopulm Dis (1966) 0.75

Improvement of medical literature. From the point of view of the author. N Y State J Med (1972) 0.75

Unipolar subclavian and bipolar femoral catheter electrodes to pace heart: comparison of effectiveness. N Y State J Med (1972) 0.75

Primary cardiomyopathy in nonanemic patients. Association with sickle cell trait. Am J Cardiol (1968) 0.75

Effect of orally administered celiprolol in patients with chronic atrial fibrillation. J Cardiovasc Pharmacol (1986) 0.75

Asymptomatic diabetic females. Exercise testing. N Y State J Med (1981) 0.75

Diastolic intervals in cardiomyopathy and abnormal thyroid states: alterations in isovolumic relaxation time and rapid filling time of depressed and enhanced myocardial contractility. Angiology (1977) 0.75

Study of daily caloric intake of patients in the coronary intensive care unit. Angiology (1975) 0.75

Clinical pathologic conference. Duchenne's muscular dystrophy. Am Heart J (1977) 0.75

Idiopathic medical ascending aortopathy with associated valvular insufficiency. Surgical correction. N Y State J Med (1969) 0.75

Alcohol induced alterations of red cell morphology in carriers of the sickle cell trait. Br J Haematol (1969) 0.75

Diabetes mellitus and impaired atrioventricular conduction. N Y State J Med (1975) 0.75

The prevention of coronary arteriosclerotic heart disease with chondroitin sulfate A: preliminary report. Exp Med Surg (1969) 0.75

Idiopathic hypertrophic subaortic stenosis. Coexistence with calcific aortic valvular stenosis and calcified mitral annulus in an elderly patient. Chest (1977) 0.75

The significance of repeated exercise testing with thallium-201 scanning in asymptomatic diabetic males. Clin Cardiol (1985) 0.75

Cardiomyopathy simulating myocardial infarction. Electrocardiographic and vectorcardiographic findings. N Y State J Med (1973) 0.75

Comparative study of the echocardiographic findings in hypertensive and nonhypertensive cardiomyopathy. Angiology (1982) 0.75

Primary pulmonary hypertension with hoarseness and massive (fatal) hemoptysis. Review of the literature and report of a case. Vasc Dis (1967) 0.75

Case report: an unusual case of gallbladder cancer in an automotive worker. CA Cancer J Clin (1981) 0.75

The ubiquitous effects of histamine phosphate on the atria of the albino mouse. Lab Invest (1974) 0.75

Effects of systemic hypertension and left ventricular hypertrophy on posterior left atrial wall motion. Am J Cardiol (1986) 0.75

Disseminated cryptococcosis in an asymptomatic alcoholic man. Arch Intern Med (1981) 0.75